Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors.
EMBO Mol Med. 2023 Oct 11;15(10):e17367. doi: 10.15252/emmm.202217367. Epub 2023 Aug 17.
EMBO Mol Med. 2023.
PMID: 37587872
Free PMC article.
MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1-Fusion-Positive Lung Cancer.
Iyer SR, Odintsov I, Schoenfeld AJ, Siau E, Mattar MS, de Stanchina E, Khodos I, Drilon A, Riely GJ, Ladanyi M, Somwar R, Davare MA.
Iyer SR, et al.
Mol Cancer Res. 2022 May 4;20(5):722-734. doi: 10.1158/1541-7786.MCR-22-0025.
Mol Cancer Res. 2022.
PMID: 35149545
Free PMC article.
Item in Clipboard
Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1-ROS1 gene fusion in pediatric angiosarcoma.
Jain P, Iyer S, Straka J, Surrey LF, Pogoriler J, Han H, Smith T, Busch C, Fox E, Li M, Waanders AJ, Resnick A, Davare MA.
Jain P, et al.
Cold Spring Harb Mol Case Stud. 2022 Oct 28;8(6):a006222. doi: 10.1101/mcs.a006222. Print 2022 Oct.
Cold Spring Harb Mol Case Stud. 2022.
PMID: 36307212
Free PMC article.
Item in Clipboard
Cite
Cite